Literature DB >> 29127726

Self-reported marijuana use over 25 years and abdominal adiposity: the Coronary Artery Risk Development in Young Adults (CARDIA) Study.

Michael P Bancks1, Reto Auer2, J Jeffrey Carr3, David C Goff4, Catarina Kiefe5, Jamal S Rana6,7, Jared Reis4, Stephen Sidney8, James G Terry3, Pamela J Schreiner9.   

Abstract

AIMS: We investigated the association between cumulative lifetime and current marijuana use with total abdominal adipose tissue (AT), visceral AT, subcutaneous AT, intermuscular AT, and mean liver attenuation (LA) at mid-life.
DESIGN: Longitudinal and cross-sectional secondary data analysis of participants in the Coronary Artery Risk Development in Young Adults (CARDIA) Study.
SETTING: CARDIA field centers in Birmingham, AL; Chicago, IL; Minneapolis, MN; and Oakland, CA, USA. PARTICIPANTS: CARDIA participants, aged 18-30 years in 1985-1986, who were present at the clinic examination in 2010-2011 (n = 2902). MEASUREMENTS: Marijuana use was assessed from responses to self-administered questionnaires at 8 CARDIA examinations over 25 years, determined as cumulative marijuana-years and current use status. Non-contrast computed tomography imaging of the abdomen was obtained in 2010-2011.
FINDINGS: In 2010-2011, 84% of participants reported a history of marijuana use with 11% reporting use within the past 30 days. Before adjustment, we observed greater cumulative marijuana use was associated with lower total abdominal and subcutaneous AT volume and lower LA and current marijuana use was associated with lower subcutaneous AT. However, after adjustment for age, sex, race, field center, cigarette pack-years and current use, regular alcohol consumption, cumulative drink-years, and physical activity, neither cumulative marijuana use nor current use showed an association with any abdominal adipose depot. Our estimates did not differ by age, sex, or race nor after accounting for cohort attrition.
CONCLUSION: Neither cumulative marijuana use nor current marijuana use is associated with total abdominal, visceral, subcutaneous, or intermuscular adipose tissue, or liver attenuation in mid-life.
© 2017 Society for the Study of Addiction.

Entities:  

Keywords:  Abdominal adiposity; computed tomography; epidemiology; marijuana use; observational; young adulthood

Mesh:

Year:  2017        PMID: 29127726      PMCID: PMC5847434          DOI: 10.1111/add.14097

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   7.256


  49 in total

1.  Marijuana use, diet, body mass index, and cardiovascular risk factors (from the CARDIA study).

Authors:  Nicolas Rodondi; Mark James Pletcher; Kiang Liu; Stephen Benjamin Hulley; Stephen Sidney
Journal:  Am J Cardiol       Date:  2006-06-19       Impact factor: 2.778

2.  Marijuana use and mortality.

Authors:  S Sidney; J E Beck; I S Tekawa; C P Quesenberry; G D Friedman
Journal:  Am J Public Health       Date:  1997-04       Impact factor: 9.308

Review 3.  The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness in healthy adults. Position stand of the American College of Sports Medicine.

Authors: 
Journal:  Schweiz Z Sportmed       Date:  1993-09

Review 4.  Cannabis use and obesity and young adults.

Authors:  Mohammad R Hayatbakhsh; Michael J O'Callaghan; Abdullah A Mamun; Gail M Williams; Alexandra Clavarino; Jake M Najman
Journal:  Am J Drug Alcohol Abuse       Date:  2010-10-12       Impact factor: 3.829

5.  Marijuana use and long-term mortality among survivors of acute myocardial infarction.

Authors:  Lauren Frost; Elizabeth Mostofsky; Joshua I Rosenbloom; Kenneth J Mukamal; Murray A Mittleman
Journal:  Am Heart J       Date:  2012-12-29       Impact factor: 4.749

Review 6.  A Systematic Review of the Respiratory Effects of Inhalational Marijuana.

Authors:  Mary P Martinasek; Jamie B McGrogan; Alisha Maysonet
Journal:  Respir Care       Date:  2016-08-09       Impact factor: 2.258

7.  Metabolic Syndrome Among Marijuana Users in the United States: An Analysis of National Health and Nutrition Examination Survey Data.

Authors:  Denise C Vidot; Guillermo Prado; WayWay M Hlaing; Hermes J Florez; Kristopher L Arheart; Sarah E Messiah
Journal:  Am J Med       Date:  2015-11-05       Impact factor: 4.965

8.  Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study.

Authors:  Adeyinka Charles Adejumo; Samson Alliu; Tokunbo Opeyemi Ajayi; Kelechi Lauretta Adejumo; Oluwole Muyiwa Adegbala; Nnaemeka Egbuna Onyeakusi; Akintunde Micheal Akinjero; Modupeoluwa Durojaiye; Terence Ndonyi Bukong
Journal:  PLoS One       Date:  2017-04-25       Impact factor: 3.240

9.  Marijuana use and risk of prediabetes and diabetes by middle adulthood: the Coronary Artery Risk Development in Young Adults (CARDIA) study.

Authors:  Michael P Bancks; Mark J Pletcher; Stefan G Kertesz; Stephen Sidney; Jamal S Rana; Pamela J Schreiner
Journal:  Diabetologia       Date:  2015-09-13       Impact factor: 10.460

10.  Association Between Lifetime Marijuana Use and Cognitive Function in Middle Age: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.

Authors:  Reto Auer; Eric Vittinghoff; Kristine Yaffe; Arnaud Künzi; Stefan G Kertesz; Deborah A Levine; Emiliano Albanese; Rachel A Whitmer; David R Jacobs; Stephen Sidney; M Maria Glymour; Mark J Pletcher
Journal:  JAMA Intern Med       Date:  2016-03       Impact factor: 44.409

View more
  2 in total

1.  Reis et al. Respond.

Authors:  Jared P Reis; Reto Auer; Michael P Bancks; David C Goff; Cora E Lewis; Mark J Pletcher; Jamal S Rana; James M Shikany; Stephen Sidney
Journal:  Am J Public Health       Date:  2018-04       Impact factor: 9.308

Review 2.  Targeting the Endocannabinoid CB1 Receptor to Treat Body Weight Disorders: A Preclinical and Clinical Review of the Therapeutic Potential of Past and Present CB1 Drugs.

Authors:  Thomas Murphy; Bernard Le Foll
Journal:  Biomolecules       Date:  2020-06-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.